Of note, attenuation of this AKT isoform impaired proliferation and anchorage-independent cell growth, and decreased the secretion of angiogenic factor VEGF and decreased the potential to metastasize to the liver in vivo, thus implicating AKT2 in multiple aspects of NB initiation and progression [226]. The gene discussed is AKT2; the disease is neuroblastoma.